Klinische studies primaire hersentumoren

Op deze pagina

Planned

There are currently no planned studies in our center.

Ongoing

There are currently no ongoing studies in our center.

Closed

CHECKMATE 498 CA209-498

A randomized phase III open-label study of nivolumab vs temozolomide each in combination with radiation therapy in newly diagnosed adult subjects with unmethylated MGMT glioblastoma

CHECKMATE 548 CA209-548

A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination With Radiation Therapy in Newly Diagnosed Adult Subjects With Unmethylated MGMT (Tumor O-6-methylguanine DNA Methyltransferase) Glioblastoma

INTELLANCE 1 M13-813

A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

STELLAR OT-15-001

A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy

Laatste aanpassing: 29 december 2021